Sort
39,280 grants matching “leukemia”
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
$553,230Glenn M Mills · Louisiana State Univ Hsc Shreveport · U10 · FY2009 · CA
Quality of Life of African American Cancer Survivors
$553,191University Of Illinois At Chicago · R01 · FY2002 · CA
Predictors of myelodysplastic syndrome in Minnesota
$553,173Julie Ann Ross · University Of Minnesota · R01 · FY2012 · CA
Combating melanoma resistance by targeting ABL1/2
$553,135Rina Plattner · University Of Kentucky · R01 · FY2024 · CA
Cytokine-induced epigenetic changes during chronic lung disease
$553,121Steven Lynn Kunkel · University Of Michigan At Ann Arbor · R01 · FY2014 · HL
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
$553,060Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2013 · CA
MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis
$553,041Seongseok Yun · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosis
$553,041Seongseok Yun · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
GP130/STAT3 signalling in articular cartilage development and regeneration
$553,025Denis Evseenko · University Of Southern California · R01 · FY2021 · AR
OCG Data Coordinating Center
$553,000Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
Next Generation gene discovery in neurogenetics
$552,974Wendy H Raskind · University Of Washington · R01 · FY2015 · NS
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$552,877Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2022 · CA
Novel pro-survival mechanisms of PIM2 in multiple myeloma
$552,872Kelvin P Lee · Indiana University Indianapolis · R01 · FY2024 · CA
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$552,832Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
$552,794Robert G Roeder · Rockefeller University · R01 · FY2013 · CA
Studies of Atomic Bomb Survivors
$552,751Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Abnormalities in gene expression in therapy-related MDS
$552,720Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2008 · HL
LY-1 B Cells: Developmental Origins and V Gene Biases
$552,272Richard R Hardy · Research Inst Of Fox Chase Can Ctr · R01 · FY2007 · AI
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2019 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$552,186Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2021 · CA
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
$552,134Jennifer A Philips · Washington University · R01 · FY2017 · AI
ITIM-receptors for cancer treatment
$551,973Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Development of Novel AIDS Gene Therapy Strategies in the Macaque SHIV Model
$551,896Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2011 · AI
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$551,891Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA